{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T20:40:08Z","timestamp":1717965608257},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11882-015-0517-1","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T08:36:23Z","timestamp":1435653383000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intratympanic Gene Delivery of Antimicrobial Molecules in Otitis Media"],"prefix":"10.1007","volume":"15","author":[{"given":"Sung K.","family":"Moon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,1]]},"reference":[{"key":"517_CR1","volume-title":"Otitis media in infants and children","author":"CD Bluestone","year":"2007","unstructured":"Bluestone CD, Klein JO. Otitis media in infants and children. London: BC Decker, Inc.; 2007."},{"key":"517_CR2","volume-title":"Microbiology in otitis media in infants and children","author":"CD Bluestone","year":"1988","unstructured":"Bluestone CD, Klein JO. Microbiology in otitis media in infants and children. Philadelphia: WB Saunders; 1988."},{"issue":"4","key":"517_CR3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0194-5998(96)70243-7","volume":"114","author":"GA Gates","year":"1996","unstructured":"Gates GA. Cost-effectiveness considerations in otitis media treatment. Otolaryngol Head Neck Surg. 1996;114(4):525\u201330.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"517_CR4","first-page":"676","volume":"129","author":"VM Howie","year":"1975","unstructured":"Howie VM, Ploussard JH, Sloyer J. The \u201cotitis-prone\u201d condition. Am J Dis Child. 1975;129(6):676\u20138.","journal-title":"Am J Dis Child"},{"issue":"1","key":"517_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/infdis\/160.1.83","volume":"160","author":"DW Teele","year":"1989","unstructured":"Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160(1):83\u201394.","journal-title":"J Infect Dis"},{"issue":"3","key":"517_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/jac\/dki257","volume":"56","author":"AE Akkerman","year":"2005","unstructured":"Akkerman AE, Kuyvenhoven MM, van der Wouden JC, Verheij TJ. Analysis of under- and overprescribing of antibiotics in acute otitis media in general practice. J Antimicrob Chemother. 2005;56(3):569\u201374.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"517_CR7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00003088-200544040-00001","volume":"44","author":"I Mahmood","year":"2005","unstructured":"Mahmood I, Green MD. Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins. Clin Pharmacokinet. 2005;44(4):331\u201347.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"517_CR8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nbt0298-153","volume":"16","author":"SD Putney","year":"1998","unstructured":"Putney SD, Burke PA. Improving protein therapeutics with sustained-release formulations. Nat Biotechnol. 1998;16(2):153\u20137.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"517_CR9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd3572-c1","volume":"11","author":"N Miller","year":"2012","unstructured":"Miller N. Glybera and the future of gene therapy in the European Union. Nat Rev Drug Discov. 2012;11(5):419.","journal-title":"Nat Rev Drug Discov"},{"issue":"21","key":"517_CR10","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","volume":"358","author":"AM Maguire","year":"2008","unstructured":"Maguire AM, Simonelli F, Pierce EA, Pugh Jr EN, Mingozzi F, Bennicelli J, et al. Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis. N Engl J Med. 2008;358(21):2240\u20138.","journal-title":"N Engl J Med"},{"issue":"7313","key":"517_CR11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","volume":"467","author":"M Cavazzana-Calvo","year":"2010","unstructured":"Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, et al. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature. 2010;467(7313):318\u201322.","journal-title":"Nature"},{"issue":"8","key":"517_CR12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","volume":"365","author":"DL Porter","year":"2011","unstructured":"Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011;365(8):725\u201333.","journal-title":"N Engl J Med"},{"key":"517_CR13","doi-asserted-by":"crossref","unstructured":"Woo JI, Kil SH, Brough DE, Lee YJ, Lim DJ, Moon SK. Therapeutic potential of adenovirus-mediated delivery of beta-defensin 2 for experimental otitis media. Innate Immun. 2014;[Epub ahead of print]. This study first demonstrates the feasibility of intratympanic gene therapy with antimicrobial molecules for the management of otitis media.","DOI":"10.1177\/1753425914534002"},{"issue":"6","key":"517_CR14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","volume":"344","author":"J Eskola","year":"2001","unstructured":"Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344(6):403\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"517_CR15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/INF.0b013e3181c1bc48","volume":"29","author":"JR Casey","year":"2010","unstructured":"Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010;29(4):304\u20139.","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"517_CR16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.inf.0000136871.51792.19","volume":"23","author":"JR Casey","year":"2004","unstructured":"Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995\u20132003. Pediatr Infect Dis J. 2004;23(9):824\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"517_CR17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/01.inf.0000136868.91756.80","volume":"23","author":"SL Block","year":"2004","unstructured":"Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23(9):829\u201333.","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"517_CR18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/INF.0b013e31828d9acc","volume":"32","author":"JR Casey","year":"2013","unstructured":"Casey JR, Kaur R, Friedel VC, Pichichero ME. Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York. Pediatr Infect Dis J. 2013;32(8):805\u20139. This study shows a bacteriological change in otitis media pathogens.","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"517_CR19","first-page":"258","volume":"59","author":"Centers for Diseases Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Diseases Control and Prevention (CDC). Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children\u2014Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2010;59(9):258\u201361.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"517_CR20","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","volume":"45","author":"GV Doern","year":"2001","unstructured":"Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995. Antimicrob Agents Chemother. 2001;45(6):1721\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"517_CR21","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1086\/595857","volume":"48","author":"SS Richter","year":"2009","unstructured":"Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004\u20132005. Clin Infect Dis. 2009;48(3):e23\u201333.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"517_CR22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1469-0691.8.s.2.5.x","volume":"8","author":"D Felmingham","year":"2002","unstructured":"Felmingham D, Feldman C, Hryniewicz W, Klugman K, Kohno S, Low DE, et al. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect. 2002;8 Suppl 2:12\u201342.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"517_CR23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","volume":"52","author":"MR Jacobs","year":"2003","unstructured":"Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN. The Alexander Project 1998\u20132000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother. 2003;52(2):229\u201346.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"517_CR24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.inf.0000253059.84602.c3","volume":"26","author":"DJ Farrell","year":"2007","unstructured":"Farrell DJ, Klugman KP, Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J. 2007;26(2):123\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"517_CR25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/171.1.93","volume":"171","author":"ML Barbour","year":"1995","unstructured":"Barbour ML, Mayon-White RT, Coles C, Crook DW, Moxon ER. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis. 1995;171(1):93\u20138.","journal-title":"J Infect Dis"},{"issue":"1","key":"517_CR26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/infdis\/173.1.180","volume":"173","author":"V Nizet","year":"1996","unstructured":"Nizet V, Colina KF, Almquist JR, Rubens CE, Smith AL. A virulent nonencapsulated Haemophilus influenzae. J Infect Dis. 1996;173(1):180\u20136.","journal-title":"J Infect Dis"},{"issue":"2","key":"517_CR27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1128\/JCM.42.2.524-529.2004","volume":"42","author":"J Campos","year":"2004","unstructured":"Campos J, Hernando M, Roman F, Perez-Vazquez M, Aracil B, Oteo J, et al. Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H influenzae type b. J Clin Microbiol. 2004;42(2):524\u20139.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"517_CR28","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1128\/JCM.41.7.3064-3069.2003","volume":"41","author":"JM O'Neill","year":"2003","unstructured":"O'Neill JM, St Geme 3rd JW, Cutter D, Adderson EE, Anyanwu J, Jacobs RF, et al. Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas. J Clin Microbiol. 2003;41(7):3064\u20139.","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"517_CR29","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0264-410X(00)00273-5","volume":"19","author":"DJ Lim","year":"2000","unstructured":"Lim DJ, Chun YM, Lee HY, Moon SK, Chang KH, Li JD, et al. Cell biology of tubotympanum in relation to pathogenesis of otitis media\u2013a review. Vaccine. 2000;19 Suppl 1:S17\u201325.","journal-title":"Vaccine"},{"key":"517_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2334-4-12","volume":"4","author":"HY Lee","year":"2004","unstructured":"Lee HY, Andalibi A, Webster P, Moon SK, Teufert K, Kang SH, et al. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect Dis. 2004;4:12.","journal-title":"BMC Infect Dis"},{"key":"517_CR31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2334-8-134","volume":"8","author":"J Shimada","year":"2008","unstructured":"Shimada J, Moon SK, Lee HY, Takeshita T, Pan H, Woo JI, et al. Lysozyme M deficiency leads to an increased susceptibility to Streptococcus pneumoniae-induced otitis media. BMC Infect Dis. 2008;8:134.","journal-title":"BMC Infect Dis"},{"key":"517_CR32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2334-6-12","volume":"6","author":"SK Moon","year":"2006","unstructured":"Moon SK, Lee HY, Pan H, Takeshita T, Park R, Cha K, et al. Synergistic effect of interleukin 1 alpha on nontypeable Haemophilus influenzae-induced up-regulation of human beta-defensin 2 in middle ear epithelial cells. BMC Infect Dis. 2006;6:12.","journal-title":"BMC Infect Dis"},{"key":"517_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2334-8-87","volume":"8","author":"HY Lee","year":"2008","unstructured":"Lee HY, Takeshita T, Shimada J, Akopyan A, Woo JI, Pan H, et al. Induction of beta defensin 2 by NTHi requires TLR2 mediated MyD88 and IRAK-TRAF6-p38MAPK signaling pathway in human middle ear epithelial cells. BMC Infect Dis. 2008;8:87.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"517_CR34","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4049\/jimmunol.178.2.1002","volume":"178","author":"DK Ho","year":"2007","unstructured":"Ho DK, Ram S, Nelson KL, Bonthuis PJ, Smith AL. lgtC expression modulates resistance to C4b deposition on an invasive nontypeable Haemophilus influenzae. J Immunol. 2007;178(2):1002\u201312.","journal-title":"J Immunol"},{"issue":"9","key":"517_CR35","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1128\/IAI.70.9.5287-5289.2002","volume":"70","author":"TD Starner","year":"2002","unstructured":"Starner TD, Swords WE, Apicella MA, McCray Jr PB. Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation. Infect Immun. 2002;70(9):5287\u20139.","journal-title":"Infect Immun"},{"issue":"1","key":"517_CR36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1128\/IAI.73.1.599-608.2005","volume":"73","author":"KM Mason","year":"2005","unstructured":"Mason KM, Munson Jr RS, Bakaletz LO. A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media. Infect Immun. 2005;73(1):599\u2013608.","journal-title":"Infect Immun"},{"key":"517_CR37","first-page":"49","volume":"136\u201340","author":"SG Stolberg","year":"1999","unstructured":"Stolberg SG. The biotech death of Jesse Gelsinger. N Y Times Mag. 1999;136\u201340:49\u201350.","journal-title":"N Y Times Mag"},{"issue":"6","key":"517_CR38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0168-9525(00)02025-4","volume":"16","author":"TD Zallen","year":"2000","unstructured":"Zallen TD. US gene therapy in crisis. Trends Gen TIG. 2000;16(6):272\u20135.","journal-title":"Trends Gen TIG"},{"issue":"1","key":"517_CR39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","volume":"122","author":"F Mingozzi","year":"2013","unstructured":"Mingozzi F, High KA. Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood. 2013;122(1):23\u201336. This review describes potential immunogenicity of viral vectors that may affect therapeutic outcomes.","journal-title":"Blood"},{"issue":"4","key":"517_CR40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","volume":"363","author":"S Hacein-Bey-Abina","year":"2010","unstructured":"Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC, et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2010;363(4):355\u201364.","journal-title":"N Engl J Med"},{"issue":"7","key":"517_CR41","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nm.3230","volume":"19","author":"C Kaeppel","year":"2013","unstructured":"Kaeppel C, Beattie SG, Fronza R, van Logtenstein R, Salmon F, Schmidt S, et al. A largely random AAV integration profile after LPLD gene therapy. Nat Med. 2013;19(7):889\u201391.","journal-title":"Nat Med"},{"issue":"Suppl 1","key":"517_CR42","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1038\/sj.gt.3302629","volume":"12","author":"P Gonin","year":"2005","unstructured":"Gonin P, Buchholz CJ, Pallardy M, Mezzina M. Gene therapy bio-safety: scientific and regulatory issues. Gene Ther. 2005;12 Suppl 1:S146\u201352.","journal-title":"Gene Ther"},{"issue":"18","key":"517_CR43","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1089\/hum.1996.7.18-2255","volume":"7","author":"BC O'Connell","year":"1996","unstructured":"O'Connell BC, Xu T, Walsh TJ, Sein T, Mastrangeli A, Crystal RG, et al. Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands. Hum Gene Ther. 1996;7(18):2255\u201361.","journal-title":"Hum Gene Ther"},{"issue":"8","key":"517_CR44","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1172\/JCI6570","volume":"103","author":"R Bals","year":"1999","unstructured":"Bals R, Weiner DJ, Meegalla RL, Wilson JM. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J Clin Invest. 1999;103(8):1113\u20137.","journal-title":"J Clin Invest"},{"issue":"20","key":"517_CR45","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/sj.gt.3302568","volume":"12","author":"F Jacobsen","year":"2005","unstructured":"Jacobsen F, Mittler D, Hirsch T, Gerhards A, Lehnhardt M, Voss B, et al. Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18\/LL-37 is effective for the treatment of burn wound infections. Gene Ther. 2005;12(20):1494\u2013502.","journal-title":"Gene Ther"},{"issue":"11","key":"517_CR46","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1128\/IAI.67.11.6084-6089.1999","volume":"67","author":"R Bals","year":"1999","unstructured":"Bals R, Weiner DJ, Moscioni AD, Meegalla RL, Wilson JM. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun. 1999;67(11):6084\u20139.","journal-title":"Infect Immun"},{"issue":"17","key":"517_CR47","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1089\/10430340260395875","volume":"13","author":"GT Huang","year":"2002","unstructured":"Huang GT, Zhang HB, Kim D, Liu L, Ganz T. A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo. Hum Gene Ther. 2002;13(17):2017\u201325.","journal-title":"Hum Gene Ther"},{"issue":"4","key":"517_CR48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/01.shk.0000224722.65929.58","volume":"26","author":"Q Shu","year":"2006","unstructured":"Shu Q, Shi Z, Zhao Z, Chen Z, Yao H, Chen Q, et al. Protection against Pseudomonas aeruginosa pneumonia and sepsis-induced lung injury by overexpression of beta- defensin-2 in rats. Shock. 2006;26(4):365\u201371.","journal-title":"Shock"},{"issue":"3","key":"517_CR49","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/jgm.1435","volume":"12","author":"Q Hu","year":"2010","unstructured":"Hu Q, Zuo P, Shao B, Yang S, Xu G, Lan F, et al. Administration of nonviral gene vector encoding rat beta-defensin-2 ameliorates chronic Pseudomonas aeruginosa lung infection in rats. J Gene Med. 2010;12(3):276\u201386.","journal-title":"J Gene Med"},{"issue":"1","key":"517_CR50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/hum.2013.161","volume":"25","author":"D Li","year":"2014","unstructured":"Li D, Wang W, Shi HS, Fu YJ, Chen X, Chen XC, et al. Gene therapy with beta-defensin 2 induces antitumor immunity and enhances local antitumor effects. Human Gene Ther. 2014;25(1):63\u201372. This study shows the secondary function of gene therapy with \u03b2-defensin 2, an anti-tumor activity.","journal-title":"Human Gene Ther"},{"issue":"3","key":"517_CR51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/1566523023347832","volume":"2","author":"A Bragonzi","year":"2002","unstructured":"Bragonzi A, Conese M. Non-viral approach toward gene therapy of cystic fibrosis lung disease. Curr Gene Ther. 2002;2(3):295\u2013305.","journal-title":"Curr Gene Ther"},{"issue":"1","key":"517_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.2003.02124.x","volume":"132","author":"S Ferrari","year":"2003","unstructured":"Ferrari S, Griesenbach U, Geddes DM, Alton E. Immunological hurdles to lung gene therapy. Clin Exp Immunol. 2003;132(1):1\u20138.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"517_CR53","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0092-8674(00)81724-9","volume":"95","author":"H Matsui","year":"1998","unstructured":"Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell. 1998;95(7):1005\u201315.","journal-title":"Cell"},{"issue":"2","key":"517_CR54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1085\/jgp.118.2.223","volume":"118","author":"R Tarran","year":"2001","unstructured":"Tarran R, Grubb BR, Gatzy JT, Davis CW, Boucher RC. The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J Gen Physiol. 2001;118(2):223\u201336.","journal-title":"J Gen Physiol"},{"issue":"Suppl 1","key":"517_CR55","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1038\/sj.gt.3302372","volume":"11","author":"E Copreni","year":"2004","unstructured":"Copreni E, Penzo M, Carrabino S, Conese M. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis. Gene Ther. 2004;11 Suppl 1:S67\u201375.","journal-title":"Gene Ther"},{"issue":"22","key":"517_CR56","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1073\/pnas.90.22.10613","volume":"90","author":"TR Flotte","year":"1993","unstructured":"Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno- associated virus vector. Proc Natl Acad Sci U S A. 1993;90(22):10613\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"517_CR57","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","volume":"61","author":"SK Lai","year":"2009","unstructured":"Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61(2):158\u201371.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"517_CR58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0092-8674(93)80063-K","volume":"75","author":"J Zabner","year":"1993","unstructured":"Zabner J, Couture LA, Gregory RJ, Graham SM, Smith AE, Welsh MJ. Adenovirus- mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell. 1993;75(2):207\u201316.","journal-title":"Cell"},{"issue":"6","key":"517_CR59","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/17425240902927841","volume":"6","author":"MK Aneja","year":"2009","unstructured":"Aneja MK, Geiger JP, Himmel A, Rudolph C. Targeted gene delivery to the lung. Exp Opin Drug Deliv. 2009;6(6):567\u201383.","journal-title":"Exp Opin Drug Deliv"},{"issue":"4","key":"517_CR60","first-page":"525","volume":"21","author":"K Podolska","year":"2012","unstructured":"Podolska K, Stachurska A, Hajdukiewicz K, Malecki M. Gene therapy prospects\u2014intranasal delivery of therapeutic genes. Adv Clin Exp Med Off Organ Wroclaw Med Univ. 2012;21(4):525\u201334.","journal-title":"Adv Clin Exp Med Off Organ Wroclaw Med Univ"},{"key":"517_CR61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1479-0556-6-5","volume":"6","author":"D Damjanovic","year":"2008","unstructured":"Damjanovic D, Zhang X, Mu J, Medina MF, Xing Z. Organ distribution of transgene expression following intranasal mucosal delivery of recombinant replication-defective adenovirus gene transfer vector. Genet Vaccines Ther. 2008;6:5.","journal-title":"Genet Vaccines Ther"},{"issue":"2","key":"517_CR62","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/mthe.2000.0244","volume":"3","author":"BG Harvey","year":"2001","unstructured":"Harvey BG, Hackett NR, Ely S, Crystal RG. Host responses and persistence of vector genome following intrabronchial administration of an E1(\u2212)E3(\u2212) adenovirus gene transfer vector to normal individuals. Mol Ther J Am Soc Gene Ther. 2001;3(2):206\u201315.","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"3","key":"517_CR63","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jmor.1051760302","volume":"176","author":"M Huangfu","year":"1983","unstructured":"Huangfu M, Saunders JC. Auditory development in the mouse: structural maturation of the middle ear. J Morphol. 1983;176(3):249\u201359.","journal-title":"J Morphol"},{"issue":"4","key":"517_CR64","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ar.1092390413","volume":"239","author":"WM Zimmer","year":"1994","unstructured":"Zimmer WM, Rosin DF, Saunders JC. Middle-ear development. VI: structural maturation of the rat conducting apparatus. Anat Rec. 1994;239(4):475\u201384.","journal-title":"Anat Rec"},{"issue":"8","key":"517_CR65","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/0036554021000028085","volume":"122","author":"JT Vrabec","year":"2002","unstructured":"Vrabec JT, Champion SW, Gomez JD, Johnson Jr RF, Chaljub G. 3D CT imaging method for measuring temporal bone aeration. Acta Otolaryngol. 2002;122(8):831\u20135.","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"517_CR66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3342\/ceo.2008.1.3.139","volume":"1","author":"JY Ahn","year":"2008","unstructured":"Ahn JY, Park HJ, Park GH, Jeong YS, Kwak HB, Lee YJ, et al. Tympanometry and CT measurement of middle ear volumes in patients with unilateral chronic otitis media. Clin Exp Otorhinolaryngol. 2008;1(3):139\u201342.","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"517_CR67","first-page":"100","volume":"457","author":"H Kawauchi","year":"1989","unstructured":"Kawauchi H, DeMaria TF, Lim DJ. Endotoxin permeability through the round window. Acta Otolaryngol Suppl. 1989;457:100\u201315.","journal-title":"Acta Otolaryngol Suppl"},{"issue":"3","key":"517_CR68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1097-0029(19970201)36:3<201::AID-JEMT8>3.0.CO;2-R","volume":"36","author":"MV Goycoolea","year":"1997","unstructured":"Goycoolea MV, Lundman L. Round window membrane. Structure function and permeability: a review. Microsc Res Tech. 1997;36(3):201\u201311.","journal-title":"Microsc Res Tech"},{"issue":"4","key":"517_CR69","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/000164801300366552","volume":"121","author":"MV Goycoolea","year":"2001","unstructured":"Goycoolea MV. Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol. 2001;121(4):437\u201347.","journal-title":"Acta Otolaryngol"},{"issue":"5","key":"517_CR70","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MOO.0b013e32833d30f0","volume":"18","author":"SN Bowe","year":"2010","unstructured":"Bowe SN, Jacob A. Round window perfusion dynamics: implications for intracochlear therapy. Curr Opin Otolaryngol Head Neck Surg. 2010;18(5):377\u201385.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"2","key":"517_CR71","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00129492-200303000-00034","volume":"24","author":"L Nordang","year":"2003","unstructured":"Nordang L, Linder B, Anniko M. Morphologic changes in round window membrane after topical hydrocortisone and dexamethasone treatment. Otol Neurotol. 2003;24(2):339\u201343.","journal-title":"Otol Neurotol"},{"issue":"6","key":"517_CR72","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archotol.1987.01860060043013","volume":"113","author":"MV Goycoolea","year":"1987","unstructured":"Goycoolea MV, Carpenter AM, Muchow D. Ultrastructural studies of the round-window membrane of the cat. Arch Otolaryngol Head Neck Surg. 1987;113(6):617\u201324.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"6","key":"517_CR73","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archotol.1987.01860060056015","volume":"113","author":"RS Sahni","year":"1987","unstructured":"Sahni RS, Paparella MM, Schachern PA, Goycoolea MV, Le CT. Thickness of the human round window membrane in different forms of otitis media. Arch Otolaryngol Head Neck Surg. 1987;113(6):630\u20134.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"11","key":"517_CR74","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1248\/bpb.b13-00383","volume":"36","author":"T Ito","year":"2013","unstructured":"Ito T, Otsuka M. Application of calcium phosphate as a controlled-release device. Biol Pharm Bull. 2013;36(11):1676\u201382.","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"517_CR75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.gene.2013.03.137","volume":"525","author":"T Wirth","year":"2013","unstructured":"Wirth T, Parker N, Yla-Herttuala S. History of gene therapy. Gene. 2013;525(2):162\u20139.","journal-title":"Gene"},{"issue":"12","key":"517_CR76","doi-asserted-by":"crossref","first-page":"9206","DOI":"10.1128\/JVI.71.12.9206-9213.1997","volume":"71","author":"DE Brough","year":"1997","unstructured":"Brough DE, Hsu C, Kulesa VA, Lee GM, Cantolupo LJ, Lizonova A, et al. Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo. J Virol. 1997;71(12):9206\u201313.","journal-title":"J Virol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-015-0517-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-015-0517-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-015-0517-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T19:32:37Z","timestamp":1717961557000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-015-0517-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["517"],"URL":"https:\/\/doi.org\/10.1007\/s11882-015-0517-1","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]},"article-number":"14"}}